Titan Pharmaceuticals is a pharmaceutical company that develops therapeutics using its proprietary long-term drug delivery platform, ProNeura, for the treatment of chronic diseases. Its products include Probuphine implant for opioid use disorder treatment and other programs such as HIV preventative therapeutic and contraceptive for women using a single ProNeura implant. The company was incorporated in 1992 and is headquartered in South San Francisco, California.